Search Results
Search results for "VIB-VUB Center for Structural Biology"
Results found for "VIB-VUB Center for Structural Biology"
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
2021 "Nov. 15, 2021 LONDON â Thereâs not yet proof of the pudding, but Omass Therapeutics Ltd.âs new structure-based
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
Structural and energetic analyses indicated that the palmitoylation of Go can allosterically stabilize
- Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs
In this review, we discuss the relationship between structure, function, and dynamics of opioid receptors
- Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...
The successful completion of this Phase 1 safety program will enable centers in Japan to be included
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
The present review describes novel findings regarding the complex biology of the preproglucagon-derived
- Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus
PVT NPSR1 neurons recruit the nucleus accumbens shell and structures in the prefrontal cortex and amygdala
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
Although the high-resolution crystal structures of the DOR with both agonist and antagonist have recently
- Therapeutic validation of an orphan G proteinâcoupled receptor
In this study Marsango et al. address two key questions in GPR84 biology and pharmacology: 1. how GPR84 and 2. which ligands can be used as tool compounds to study the function and biology of this receptor
- Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental...
of membrane proteins in eukaryotes and the largest drug target family to date, exhibit diversity in structure
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
the Company Through the Next Stage of its Evolution "New team focused on expanding its GPCR-focused structure-based
- Why âDisplacementâ Misleads You: Allosteric Binding Demystified
increases radioligand binding but suppresses functional response, itâs not broken pharmacologyâitâs biology
- New Resources in GPCRdb
present and demonstrate the newest resources of the GPCRdb: 1) the new G protein resources and 2) the structural
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
binding location that raises many questions about the ligand interactions and stability, the binding site structure
- Reflections on My PhD Journey: Lessons Learned
is simple: choose a lab and mentor that align with your values and goals, embrace the discipline of structured
- GRK2 in cardiovascular disease and its potential as a therapeutic target
This perspective reviews cardiac GPCRs, describes the structure and functions of GRK2 in cardiac function
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
Must-read publications:  GPCRs in neurological disorders; OSTα-OSTÎČ structure; GPCRâG proteinâÎČ-arrestin GPCR Ecosystem is entering its most ambitious phase yet.
- Ode to GPCRs
discover that sensing smell involved a large number of relatively specific olfactory receptors that are structurally 66] Lefkowitz was able to isolate ÎČ-adrenergic receptors from tissue samples to carry out the first structure-function rhodopsin.[67] In 2011, Kobilka further contributed to the field by obtaining the first X-ray crystal structure Non-traditional roles of G protein-coupled receptors in basic cell biology.
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of ”-opioid receptors
relieves severe pain by activating the Ό-opioid receptor (MOR), whereas naloxone, with only slight structural
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
Investors want to see that the team understands the landscape it is entering. đ Why do these gaps matter Expectations around intellectual property in biotech fundraising are becoming more structured. This shift is not about stricter rules, but about earlier and clearer risk assessment .
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
present the PKC KO cell lines as more specific research tools to investigate PKC-mediated aspects of cell biology
- Latrophilin-1 drives neuron morphogenesis and shapes chemo- and mechanosensation-dependent ...
Here, we show that Latrophilin-1 acts in trans to mediate morphogenesis of sensory structures in the
- Effects of Small Molecule Ligands on ACKR3 Receptors
appreciate the unique roles of ACKR3 in the CXCL12/CXCR4/ACKR3-signaling axis and better understand the structural
- Differential binding of Î9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
The bias depends on the agonistâs structure as well as the state of the cannabinoid receptor (whether
- Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2
Prokineticins (PKs) exert their biological functions through the activation of the G protein-coupled Our data support the idea of a modulatory role of anosmin 1 in the biological effects controlled by the
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
This unpredictability isnât chaosâitâs structure-driven , and when properly understood, it becomes a
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
how a series of bold pivotsâfrom Cisbioâs HTRF platform to IP-One and now pHSenseâreshaped how GPCR biology
- The Five Traps of Ignoring Kinetics
But biology isnât tidy.
- Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
focused on the potentially clinical effects of psychedelics on human subjects tend to exclude sex as a biological profiles of the 5-HT2AR agonist DOI in C57BL/6J mice, and support the importance of studying sex as a biological
- Discovery On Target, October 17-20, 2022, Boston, USA
target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics
- Advancements in G protein-coupled receptor biosensors to study GPCR-G protein coupling
October 2022 "Enzymatic and cellular signalling biosensors are used to decipher the activities of complex biological








